Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I have followed several OTC stocks, this one "feels" different to me for some reason. a few of the ones I followed have many splits like this but they seemed to have no product, no brand recognition and no media exposure or coverage. This company HAS a REAL product, it IS a real company. Now, whether it can perform and delivery on it's strategy is the question.
There is one thing I find curious, though. I believe Keith Fitz-Gerald and Co. are frequent guests on CNBC. How involved are Fitz and Co. when it comes to their investment in EKSO? Were they involved in getting EKSO covered with this upcoming airing on CNBC?They always send me emails about a venture capital guy that gets, behind small up and coming companies in the tech space. Is this one of them?
According to the release, they believe they meet all the other criteria. Stock price must remain above $4.00 for 30 days, then they will file. That does not mean they will be approved.
If they believe they are going to have a good earning report or are sitting on some kind of news for the 10th, this would be the best time for the split, good news would almost ensure it stays above the $ 4.00. I am expecting an initial hit to share price from people who either don't like the split or are afraid to wait and see what else happens in the coming weeks. I am in the camp that thinks something big is brewing. I will add to my position with a pull back to the level of my last share purchase.
Look at my username....I have a stake but definitely not the farm invested in this. The money I have in this stock is house money from my slightly over 1,700% gain in Baidu over the years.
It seems to me, that there is a lot of "stuff" happening with EKSO lately, (News report coverage, CNBC to air coverage, reverse split, etc., right before earnings and company update) for something not to be happening behind the scenes. I do believe there is something major going on that will really change the share price soon.
This should help get the EKSO news out there.
http://philadelphia.cbslocal.com/2016/05/04/magee-rehabilitation-hospital-unveils-bionic-suit-for-use-with-stroke-and-spinal-cord-injuries/
While I understand the need to be listed on the NASDAQ and the requirements to do so, I have seen several OTC companies reverse split "in preparation for uplisting" and then their share price falling back down below that which is required and then the stock never gets uplisted. That said, I do not believe EKSO acts like those companies and it's share price acts more like a listed stock anyway.
Could this mean that there is some good news coming on, 10 May, with the earnings release and company update?
Soldier Strong to Donate EKSO GT
http://markets.financialcontent.com/stocks/news/read?GUID=32033963
PUSH IT BAYBEEEE!!!! Above 1.02, no 1.10, no 2.00...massive break...Sorry, I just had to. You know it's coming! LOL
I don't think this article is quite accurate where it mentions the following:
Bionik's breadth of product offering is much bigger than Ekso. Whereas the latter (meaning EKSO) caters to industries other than healthcare (factory workers and soldiers) to aid in lifting and carrying heavy loads, Bionik keeps laser-focused on its core competency: bringing patients closer to normal movement. In addition to ARKE, its unparalleled robotics technology is applied to arms, hands, wrists, ankles and knees, using proprietary intelligent interactive expertise that senses movement and limitations in a feedback loop to give the disabled help, as needed, in real-time. Offering even more value and credibility to its innovations, devices were designed and built in conjunction with MIT.
http://finance.yahoo.com/news/bionik-labs-exoskeleton-bests-products-130000261.html
We got our share price bump from that news. It is my opinion, one reason for the difference in reaction is that EKSO's clearance is targeted for a different category of injury patients, which the sales market (or potential sales) has not picked up yet. While I realize that R&D spending is important, money in has to start approaching money out before share price rises. Hopefully there were some contracts in the works that were just being held up until FDA gave clearance and we will hear something soon before this falls back to high .70's low .80's again.
What happened to ALL-IN888? ...far from "2.00 by weeks end"!...this is how it ALWAYS ends with those guys...
I believe the reason for the drop in PPS is 1.) guys like ALL-IN, have been selling off, 2.)and I think this is a bigger reason, there simply has not been any follow up good news so people are moving on. When we see device sales contracts, good earnings or news of advances in their product the PPS will increase and not until then.
This is a long article but very in depth explanation of what EKSO and other companies are working through as they develop their products and where the competition is in terms of their progress. The first part of the article is about BNKL, an EKSO competitor in the Canadian market. They are striving to reach some of the goals that EKSO has already reached.
http://seekingalpha.com/article/3965563-bioniks-arke-looking-take-share-nascent-medical-exoskeleton-market
There are 3 points on the chart that I am looking at, (1)end of June 2015 (2)end of July/beginning of August 2015 and (3)beginning of Jan 2016. They were support when share price was dropping. After the 3rd time it failed to hold and dropped to about .68. Those old support levels are now the resistance that we must break to get to the next level of mid to upper teens which was support for almost all of October 2015 and then again in December of 2015.
The part of the chart that I like is the "capitulation" around Jan 20, '16 on oversold condition with a retesting of that low, immediately followed by a sharp rise in price on heavy volume, which saw the 10 day break above the 50 day MA. The sharp rise was a news driven event, followed by a Keith Fitz-Gerald newsletter article circulating. Other moves up in price were also after Fitz-Gerald articles were circulated.
Comments welcomed.
Also hovering just barely under overbought condition.
I just read that EKSO's 200 day MA is 1.04, looking at the chart I thought it was a bit higher than that, but I keep looking at the 52 week chart, twice the 10 day was above the 50 day and reached the 200 day but could not get above it and then slide back down. That is what I am looking for as the true break out sign that it will go to 2.00 or more but I really believe that has to be news driven.
I do agree that there does seem to be excitement building. There have been a lot more articles (most just rehashing the same news) but it still has to be helping to get the word out. Also stock trading newsletters are mentioning it more.
If Ekso releases another progress report with very good news, then you just may see that explosion you keep mentioning. BUT, I do think it is going to take news to do it.
I think it is great that it is holding steady at this level. Seems people are willing to be a little patient. I think there may have been some accumulation of shares by many people in anticipation of some kind of good news that will come about as a result of the recent clearance by the FDA.(sales contracts)
If that news doesn't come, the longer we don't hear anything, I think we slide back again.
If the news is not good, then it drops quickly.
Either way, a chance to pick up some more.
I do believe in EKSO!
No, he said break ABOVE 1.01. Still waiting!
Although, it is nice to see it at 1.00 at close. Very tight range today.
For all our sake, I hope it does.
Most of this article, we have heard before but it is still good to see that the news of the EKSO name and the technology is spreading.
http://www.healthline.com/health-news/exoskeletons-helping-paralyzed-walk#1
Close but no cigar! We still didn't break 1.01.
We need to break that resistance, then next level is mid-teens. I don't think all the cheerleading in the world will cause that. We need some kind of news for that to happen.
Received an email from Total Wealth (Keith Fitz-Gerald). It was just a re-stating of his article that was released a couple days ago. I don't think it will have much, if any, effect on the share price.
It would be nice to hear some sales news or even just some news of progress being made with regard to their devices.
How many times are you going to say that and be wrong? That makes 4.
Please keep your posts about company related news and technological developments that concern the company.
This could explain why share prices reacted the way they did from December through January. Obviously, things have changed since then. This article gives insight into the thinking at that time, about the Equipoise acquisition.
http://exoskeletonreport.com/2015/12/in-an-aggressive-move-ekso-bionics-acquires-zerog-technology/
My question is what happened to the two predicted massive breaks above 1.01 and the massive break above 1.09? Not looking good to make it to 2.00 by weeks end or 8.00 any time soon either. Reality check!
Looking at the 52 week chart...the mid teens level would be at the 200 day MA. Breaking that would be huge. The last 2 attempts to break the 200 MDA have failed.
Bid/ask .9975/1.00 with a last of 1.00 ...20,000 shares Pre-market
Looks like the next level to break is around 1.05 then mid-teens and then the mid 1.30's. I really think it will take news to get above 1.05, not just momentum.
Ecco...that's what I was referring to in my post on the 4th (#1428)
Their are only a few people on the board that really have long term views on EKSO and are truly concerned about the company and the advancements they are making for the patients who use the devices.
As for the recent little run in share price, I think it will level off here. The move was due to the news of FDA clearance (days old news), the article by Keith Fitz-Gerald and also the volume brought by the pumpers. Unless tons more pumpers are out there (which may bring a temporary jump in price, but also the rapid decline in price)Ekso needs more news or good financial results to get us to the next level.
According to Ameritrade last trade was .90...
Early bid/ask ....865/.87
Like I said on the 4th, (post 1489).... Now lets hope his comments can help break through the resistance at .88-.90. If it can do that I believe we can see above 1.00 very quickly. I think it will take more news, like sales/rental contracts or good earnings report to get higher than that.
Thanks for the heads up Loujohn, had to look in my junk mail to find the report. All their other junk mailings come through but the one I subscribed to goes to junk. !?!
Robotics, DARPA, Boston Dynamics...gives you an idea of robotics technology advances
It seems it is still being debated (other board)what it actually means for EKSO going forward. They seem to agree it is a good step forward, but some are in the camp that says it is not the game changer we were hoping for.
To tell you the truth I was thinking the same thing you were.
No close above resistance which I was hoping for (.90), MAYBE we can get another high volume push tomorrow. It is still better than the .74 we were looking at this AM before it opened.
Here is another link concerning the recent announcement, a slightly different take on the story.
http://www.bizjournals.com/sanfrancisco/blog/2016/04/ekso-bionics-ekoskeleton-stroke-spinal-cord-injury.html
Looby acknowledged it may take several years for the company to become profitable, but said over the last two years it has focused intensively on commercialization, including expanding its engineering services business. That unit has won big grants from federal agencies such as the U.S. Department of Defense and the National Institutes of Health.
Making money on medical devices "is a long road," Looby told me Monday, in part due to lower than ideal reimbursement. "But this is a great milestone."
My concern is the fact that it has spent about 5 hours, making repeated attempts to break the resistance at .87-.88 with no luck.
I'm thinking either breakout or slow slide back to low to mid .70's
An explanation of "cleared" vs. "approved" from a post from another message board
What does it mean when FDA "clears" or "approves" a medical device?
When FDA review is needed prior to marketing a medical device, FDA will either
"clear" the device after reviewing a premarket notification, otherwise known as a 510(k) (named for a section in the Food, Drug, and Cosmetic Act), that has been filed with FDA, or
"approve" the device after reviewing a premarket approval (PMA) application that has been submitted to FDA.
Whether a 510(k) or a PMA application needs to be filed depends on the classification of the medical device.
To acquire clearance to market a device using the 510(k) pathway, the submitter of the 510(k) must show that the medical device is "substantially equivalent" to a device that is already legally marketed for the same use.
To acquire approval of a device through a PMA application, the PMA applicant must provide reasonable assurance of the device’s safety and effectiveness. Less
This is from my Ameritrade EKSO page just now
H.C. Wainwright Says FDA Clearance Of EKSO's GT Robotic Exoskeleton Removes Key Overhang In Story, Calls Win 'important', Sees CEO Gaining Credibility On Delivering Timely Milestones, Reiterates Buy & $3 PT
Also guessing we will be hearing from Keith Fitz-Gerald at Total Wealth shortly.
Rhet...was is your avg./share again? I'm at .9455
Now if you look at a 52 week chart, (if I am reading this correctly)it has hit a resistance level if it can break .90 and close there it will have broken resistance and 50 MA on heavy volume and good news. What do you think?